Public research preview

Byron Donalds, Representative disclosure: Regeneron Pharmaceuticals, Inc. - Common Stock (REGN)

Disclosed a sell transaction in Regeneron Pharmaceuticals, Inc. - Common Stock (REGN). Use this page to inspect source evidence, confidence scores, filing delay, and post-disclosure price movement before deciding whether to research the signal further.

Copy Window
Sandsynligvis for sent
24/100
Signalkvalitet
34/100
Datakvalitet
93%
Høj kvalitet

This public page is for public-disclosure research only. It is not investment advice and does not place orders. Verify the official source before relying on any signal.

Evidence passport

Official-source context and parser confidence before any simulation or alert decision.

Source
House STOCK Act disclosures
Published
24 May 2025, 00:00
Parser confidence
94%
Instrument mapping
95%
Filing delay
44 days

Tidslinje

Transaktionsdato

10 Apr 2025

Offentliggørelse

24 May 2025

Nu

Sporet i dag

Indberetningsforsinkelse: 44 dage

Kursbevægelse

Delvis dækning

Udbyder
Yahoo Finance daily close
Hentet
21. sep. 2026

Missing Yahoo Finance daily close for disclosure date 2025-05-24.

Kursforløb

REGN fra kontekst før transaktionen til seneste lukkekurs.

Transaktion

10. apr. 2025 · 541,978 USD · Endnu ikke offentlig

Systemets beslutning

Ville ikke købe — Strategiens filtre afviser dette signal. Fejlede filtre: Buy disclosure · Filed within 30 days · Pre-disclosure move <= 35%.

Endnu ikke offentligVille ikke købe479,9835,21.190,5USDDato6. mar.10. apr.21. sep.Officiel offentliggørelse24. majTransaktionSeneste
  • Endnu ikke offentlig
  • Ville ikke købe
Fallbackkurs ved transaktion
—
Fallbackkurs ved offentliggørelse
—
Seneste fallbackkurs
—
Bevægelse før indberetning
—
Bevægelse efter indberetning
—
Markedsjusteret bevægelse
—
1w since disclosure
—
1m since disclosure
—
3m since disclosure
—
Topstigning før indberetning
+12,7 %
Tilbagetrækning fra top
-4,3 %

Why Copy Window is Probably too late

Supporting factors

  • Parsed sell disclosure for ordinary shares from House STOCK Act disclosures.
  • Reported amount is $1,001 - $15,000.
  • Post-disclosure move is currently treated as 0% because market-price coverage is unavailable.

Cautions

  • Missing Yahoo Finance daily close for disclosure date 2025-05-24.
  • Copy Window is using a transaction-price fallback until coverage improves.
  • Price coverage is partial; accepted for official-source intake before market data enrichment.
  • Review the original source document before making any investment decision.

Source document

House STOCK Act disclosures, published 24 May 2025, 00:00

View source
Parser confidence
94%
Instrument mapping
95%
FieldExtracted value
roleRepresentative
sidesell
value1001
sourcehouse_stock_act
tickerREGN
chamberHouse
currencyUSD
assetTypestock
sourceUrlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2025/20030342.pdf
personNameByron Donalds
amountRange$1,001 - $15,000
companyNameRegeneron Pharmaceuticals, Inc. - Common Stock (REGN)
publishedAt2025-05-24T00:00:00.000Z
rawDocumentIdraw-us-house-20030342-5
disclosureDate2025-05-24
transactionDate2025-04-10
transactionTypeS